Transgenic mouse model of AA amyloidosis

American Journal of Pathology

Volumn 154, Issue 4, 1999, Pages 1267-1272

  Solomon, Alan ^a   Weiss, Deborah T ^a   Schell, Maria ^a   Hrncic, Rudi ^a   Murphy, Charles L ^a   Wall, Jonathan ^a   McGavin, M Donald ^a   Pan, Hong Jun ^b   Kabalka, George W ^b   Paulus, Michael J ^c  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID A PROTEIN; INTERLEUKIN 6; METALLOTHIONEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE MODEL; FEMALE; GENE CONTROL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPLEEN; TRANSGENE;

EID: 0032899037     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65378-3     Document Type: Article

References (29)

1. Skinner M, Shirahama T, Benson MD, Cohen AS: Murine amyloid protein AA in casein induced experimental amyloidosis. Lab Invest 1997, 36:420-427
2. Kisilevsky R, Young ID: Pathogenesis of amyloidosis. Bailliere's Clinical Rheumatology: Reactive Amyloidosis and the Acute-Phase Response. Vol 8, no 3. Edited by G Husby. London, Bailliere Tindall, 1994, pp 613-626
3. Sipe JD: Amyloidosis. Crit Rev Clin Lab Sci 1994, 31:325-354
4. Husebekk A, Skogen B, Husby G, Marhaug G: Transformation of amyloid precursor SAA to protein AA and incorporation into amyloid fibrils in vivo. Scand J Immunol 1985, 21:282-287
5. Tape C, Tan R, Nesheim M, Kisilevsky R: Direct evidence for circulating apo-SAA as the precursor of tissue AA amyloid deposits. Scand J Immunol 1988, 28:317-324
6. Sipe JD: Amyloidosis. Annu Rev Biochem 1992, 61:947-975
7. Husby G, Marhaug G, Dowton B, Sletten K, Sipe JD: Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amylodosis. Amyloid Int J Exp Clin Invest 1994, 1:119-137
8. Kishimoto T, Hirano T: Molecular regulation of β lymphocyte response. Annu Rev Immunol 1988, 6:485-512
9. Le J, Vilcek J: Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989, 61:588-602
10. Hirano T, Akira S, Taga T, Kishimoto T: Biological and clinical aspects of interleukin 6. Immunol Today 1990, 11:443-449
11. Van Snick J: Interleukin 6: an overview. Annu Rev Immunol 1990, 8:253-257
12. Fattori E, Cappelletti M, Costa P, Sellitto C, Cantoni L, Carelli M, Faggioni R, Fontuzza G, Ghezzi P, Poli V: Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 1994, 180:1243-1250
13. Brandt SJ, Bodine, DM, Dunbar CE, Nienhuis AW: Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 1990, 86:592-599
14. Woodroofe C, Müller W, Rüther U: Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell Biol 1992, 11:587-592
15. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T: IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 1989, 86:7547-7551
16. Fattori E, Della-Rocca C, Costa P, Giorgio M, Dente B, Pozzi L, Ciliberto G: Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 1994, 83:2570-2579
17. Meek RL, Hoffman JS, Benditt EP: Amyloidogenesis: one serum amyloid A isotype is selectively removed from circulation. J Exp Med 1986, 163:499-510
18. Sim GK, Kafatos FC, Jones CW, Koehler MD, Efstratiadis A, Maniatis T: Use of a cDNA library for studies on evolution and developmental expression of the chorion multigene families. Cell 1979, 18:1303-1316
19. Solomon A, Weiss DT, Macy SD, Antonucci RA: Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies. Am J Pathol 1990, 137:855-862
20. Pras M, Shubert M, Zucker-Franklin D, Rimon A, Franklin EC: The characterization of soluble amyloid prepared in water. J Clin Invest 1968, 47:924-933
21. Eulitz M, Weiss DT, Solomon A: Immunoglobulin heavy-chain-associated amyloidosis. Proc Natl Acad Sci USA 1996, 87:6542-6546
22. Foyn Bruun C, Rygg M, Nordstoga K, Sletten K, Marhaug G: Serum amyloid A protein in mink during endotoxin induced inflammation and amyloidogenesis. Scand J Immunol 1994, 40:337-344
23. Prelli F, Pras M, Shtrasburg S, Frangione B: Characterization of high molecular weight amyloid A proteins. Scand J Immunol 1991, 33:783-7866
24. Nordstoga K, Zhou ZY, Husby G: Bovine glomerular amyloidosis: morphological studies. Zentralbl Veterinarmed A 1994, 41:741-747
25. Gillmore JD, Hawkins PN, Pepys MB: Amyloidosis: a review of recent diagnostic and therapeutic developments. Brit J Haematol 1997, 99:245-256
26. Palmiter RD, Brinster RL: Germ-line transformation of mice. Annu Rev Genet 1986, 20:465-499
27. Suematsu S, Matsusaka T, Matsuda T, Ohno S, Miyazaki J, Yamamura K, Hirano T, and Kishimoto T: Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 1991, 89:232-235
28. Coe JE, Ross MJ: Amyloidosis and female protein in the Syrian hamster: concurrent regulation by sex hormones. J Exp Med 1990, 171:1257-1267
29. Axelrad MA, Kisilevsky R, Willmer J, Chen SJ, Skinner M: Further characterizations of amyloid-enhancing factor. Lab Invest 1982, 47: 139-146